BCS(BCS)
BCS
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $41.67B | $43.73B | $45.71B | $46.02B | $47.20B |
| Low | $41.63B | $43.71B | $45.26B | $45.56B | $46.72B |
| High | $41.72B | $43.75B | $46.09B | $46.39B | $47.58B |
| EBITDA Avg | $9.44B | $9.90B | $10.35B | $10.42B | $10.69B |
| Low | $9.43B | $9.90B | $10.25B | $10.32B | $10.58B |
| High | $9.45B | $9.91B | $10.44B | $10.50B | $10.77B |
| EBIT Avg | $8.26B | $8.67B | $9.07B | $9.13B | $9.36B |
| Low | $8.26B | $8.67B | $8.97B | $9.03B | $9.27B |
| High | $8.27B | $8.68B | $9.14B | $9.20B | $9.44B |
| Net Income Avg | $9.73B | $11.90B | $13.93B | $13.87B | $16.30B |
| Low | $9.49B | $11.51B | $13.74B | $13.69B | $16.08B |
| High | $10.01B | $12.31B | $14.07B | $14.02B | $16.47B |
| EPS Avg | $2.82 | $3.45 | $4.04 | $4.02 | $4.72 |
| Low | $2.75 | $3.34 | $3.98 | $3.97 | $4.66 |
| High | $2.90 | $3.57 | $4.08 | $4.06 | $4.77 |
| Analysts (Rev / EPS) | 9 / 2 | 9 / 2 | 3 / 1 | 4 / 1 | 4 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $10.24B | $9.91B | $12.02B |
| Low | $10.21B | $9.88B | $11.99B |
| High | $10.26B | $9.93B | $12.05B |
| EBITDA Avg | $2.32B | $2.24B | $2.72B |
| Low | $2.31B | $2.24B | $2.72B |
| High | $2.32B | $2.25B | $2.73B |
| EBIT Avg | $2.03B | $1.96B | $2.38B |
| Low | $2.03B | $1.96B | $2.38B |
| High | $2.03B | $1.97B | $2.39B |
| Net Income Avg | $2.38B | $1.82B | $3.73B |
| Low | $2.38B | $1.81B | $3.72B |
| High | $2.39B | $1.82B | $3.74B |
| EPS Avg | $0.69 | $0.53 | $1.09 |
| Low | $0.69 | $0.53 | $1.08 |
| High | $0.70 | $0.53 | $1.09 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |